Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
96 studies found for:    "Vulvar cancer"
Show Display Options
Rank Status Study
1 Recruiting Groin Sentinel Node Biopsy and 18FDG-PET/CT in cN0 Vulvar Cancer Patients Candidate to Standard Lymphadenectomy
Condition: Vulvar Cancer
Interventions: Procedure: 18FDG-PET/TC;   Procedure: Sentinel node biopsy
2 Completed Conservative Management With Isolated Sentinel Lymph Node Biopsy in Vulvar Cancer Patients.
Condition: Vulvar Cancer
Intervention: Procedure: Sentinel Node Biopsy
3 Terminated Radiation Therapy With or Without Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Cancer of the Vulva
Condition: Vulvar Cancer
Interventions: Drug: cisplatin;   Radiation: radiation therapy
4 Completed Radiation Therapy or Surgery in Treating Patients With Previously Untreated Vulva Cancer With Positive Groin Lymph Nodes
Condition: Vulvar Cancer
Interventions: Procedure: regional lymph node dissection;   Radiation: radiation therapy
5 Completed Lymphatic Mapping in Treating Patients With Stage I or Stage II Cancer of the Vulva
Condition: Vulvar Cancer
Intervention: Procedure: Sentinel lymph node mapping
6 Completed Chemo- and Radiotherapy in Epithelial Vulvar Cancer
Condition: Radio/Chemotherapy in Node Positive Advanced Vulvar Cancer
Intervention:
7 Completed Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the Vulva
Condition: Vulvar Cancer
Interventions: Drug: cisplatin;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Radiation: radiation therapy
8 Completed Paclitaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Vulva
Condition: Vulvar Cancer
Intervention: Drug: paclitaxel
9 Recruiting Ultrasound Morphometric and Cyto/Histological Combined Pre-operative Assessment of Inguinal Lymph Node Status in Women With Invasive Vulvar Carcinoma
Condition: Vulvar Cancer
Intervention: Procedure: Groin ultrasound +/- fine needle aspiration
10 Recruiting New Strategy for the Treatment of Vulvar Cancer
Condition: Vulvar Neoplasm
Interventions: Procedure: Surgery, radiotherapy and chemotherapy;   Procedure: Surgery
11 Terminated
Has Results
A Non-Randomized Study to Evaluate Leg Lymphatic Drainage Associated With Surgical Intervention for Vulvar Cancer
Condition: Vulvar Cancer
Intervention: Procedure: Routine Leg edema and groin dissection
12 Unknown  A New Patient Reported Outcome Instrument to Assess Symptom Experience in Women With Vulvar Neoplasms (WOMAN-PRO)
Condition: Women With Vulvar Intraephitelial Neoplasia or Vulvar Cancer
Intervention:
13 Active, not recruiting Topical Imiquimod in Treating Patients With Recurrent Paget's Disease of the Vulva
Condition: Vulvar Cancer
Interventions: Drug: imiquimod;   Procedure: biopsy;   Procedure: therapeutic conventional surgery
14 Active, not recruiting Observation in Patients With Early-Stage Vulvar Cancer Undergoing Sentinel Lymph Node Dissection
Conditions: Long-Term Effects Secondary to Cancer Therapy in Adults;   Stage I Vulvar Cancer;   Stage II Vulvar Cancer;   Stage III Vulvar Cancer;   Vulvar Squamous Cell Carcinoma
Intervention: Other: Clinical Observation
15 Withdrawn Chemoprevention of Cancer in the Lower Female Genital Tract: The Antineoplastic Activity of the Fungicide Ciclopirox.
Condition: Vulvar Cancer
Intervention: Drug: Ciclopirox
16 Active, not recruiting Bioimpedance Spectroscopy in Detecting Lower-Extremity Lymphedema in Patients With Stage I, Stage II, Stage III, or Stage IV Vulvar Cancer Undergoing Surgery and Lymphadenectomy
Conditions: Lymphedema;   Perioperative/Postoperative Complications;   Stage IA Vulvar Cancer;   Stage IB Vulvar Cancer;   Stage II Vulvar Cancer;   Stage IIIA Vulvar Cancer;   Stage IIIB Vulvar Cancer;   Stage IIIC Vulvar Cancer;   Stage IVA Vulvar Cancer;   Stage IVB Vulvar Cancer
Interventions: Procedure: Bioelectric Impedance Analysis;   Procedure: Lymphadenectomy;   Procedure: Therapeutic Conventional Surgery
17 Completed Added-value of SPECT/CT in Patients Undergoing LM/SL for Gynecological Cancers
Conditions: Cervical Cancer;   Vulvar Cancer
Intervention: Device: SPECT/CT guided LM/SL
18 Suspended Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Carcinoma of the Vulva
Conditions: Stage IIIA Vulvar Cancer;   Stage IIIB Vulvar Cancer;   Stage IIIC Vulvar Cancer;   Stage IVA Vulvar Cancer;   Vulvar Squamous Cell Carcinoma
Interventions: Drug: Cisplatin;   Drug: Gemcitabine Hydrochloride;   Radiation: Intensity-Modulated Radiation Therapy;   Procedure: Therapeutic Conventional Surgery
19 Suspended Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vulvar Cancer
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Carcinoma;   Cervical Squamous Cell Carcinoma, Not Otherwise Specified;   Stage IB Vulvar Cancer;   Stage IB2 Cervical Cancer;   Stage II Vulvar Cancer;   Stage IIA1 Cervical Cancer;   Stage IIA2 Cervical Cancer;   Stage IIB Cervical Cancer;   Stage IIIA Cervical Cancer;   Stage IIIA Vulvar Cancer;   Stage IIIB Cervical Cancer;   Stage IIIB Vulvar Cancer;   Stage IIIC Vulvar Cancer;   Stage IVA Cervical Cancer;   Stage IVA Vulvar Cancer;   Vulvar Adenocarcinoma;   Vulvar Squamous Cell Carcinoma
Interventions: Drug: Cisplatin;   Radiation: External Beam Radiation Therapy;   Radiation: High-Dose Rate Brachytherapy;   Radiation: Intensity-Modulated Radiation Therapy;   Radiation: Internal Radiation Therapy;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Triapine
20 Unknown  Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix and/or Vulva
Conditions: Cervical Cancer;   Vulvar Cancer
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.